DENVER–(BUSINESS WIRE)–Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or “the Company”) today announced Shane Sampson has been named Chief Marketing and Merchandising Officer, reporting directly to Justin Dye, Chief Executive Officer. In this newly created role, Sampson will provide strategic direction and manage tactical execution of the Company’s marketing, merchandising, brand management, IP licensing programs, digital strategy including e-commerce, and retail operations.
“Shane is a proven leader with virtually unmatched breadth and depth of retail and consumer goods expertise,” said Justin Dye, Chief Executive Officer. “Having worked closely with Shane at Albertsons Companies during exponential growth, I have come to appreciate and admire his keen eye and skillset in creating robust brand and product programs. Additionally, the emphasis he places on ensuring that customer needs are met in all situations is one of care and thoughtfulness. His omnichannel knowledge will be invaluable to Medicine Man Technologies. I am confident the Company will greatly benefit from his guidance. He is a great leader and I am excited to work together again.”
“I am excited to join Medicine Man Technologies and contribute to the growth of the emerging cannabis industry,” added Shane Sampson. “We have a unique opportunity to bring knowledge from manufacturing, distribution, retail and consumer packaged goods to one of the most innovative and fastest growing spaces. Medicine Man Technologies’ strategy brings together some of the strongest Colorado cannabis operators and paves the way for us to create one of the most admired companies in cannabis. I look forward to sharing my passion and experience as we create a leading vertically integrated cannabis company.”
Sampson has more than 35 years of extensive experience building iconic brands, leading innovative and fully integrated marketing and merchandising programs and strategic operations. Most recently, Sampson served as Chief Marketing and Merchandising Officer for Albertsons Companies. There he was instrumental in leading the company during a period of monumental growth through strategic merchandising approaches, oversaw significant development and innovation through digital and e-commerce strategies, rapidly scaled its private label brands and built customer and associate engagement across 2,300 stores. Prior to his position as Chief Marketing and Merchandising Officer at Albertsons, Sampson held numerous leadership roles at Albertsons Companies, Ahold’s Giant of Landover and Walmart’s Sam’s Club spanning operations, product merchandising and procurement, e-commerce and branding. In 2017, Sampson was named Mass Market Retailer’s Merchant of the Year and received the Retail TouchPoints’ 2018 Retail Innovator Award.
For more information about Medicine Man Technologies, please visit https://www.MedicineManTechnologies.com
About Medicine Man Technologies
Denver, Colorado-based Medicine Man Technologies (OTCQX: MDCL) is a rapidly growing provider of cannabis consulting services, nutrients, and supplies. The Company’s client portfolio includes active and past clients throughout the cannabis industry in 20 states and seven countries. The Company has entered into agreements to become one of the largest vertically integrated seed-to-sale operators in the global cannabis industry. Current agreements will enable Medicine Man Technologies to offer cultivation, extraction, distribution and retail pharma-grade products. Management includes decades of cannabis experience, a unique combination of first movers in industrial cannabis and proven Fortune 500 corporate executives.
This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.